immune system
• exacerbated in mice infected with murine AIDS virus (LP-BM5 strain of Mo-MLV)
|
• exacerbated in mice infected with murine AIDS virus (LP-BM5 strain of Mo-MLV)
|
• pIpC-treated mice exhibit increased Mo-MLV plasma viremia compared with wild-type mice
• mice infected with murine AIDS virus (LP-BM5 strain of Mo-MLV) exhibit increased viremia and exacerbated disease with increased splenomegaly and lymphadenopathy compared with wild-type mice
• however, mice exhibit normal response to Mo-MLV infection
|
cellular
• IFNalpha-treated mouse embryonic fibroblasts exhibit reduced antiretroviral activity as determined by Moloney murine leukemia virus (Mo-MLV) replication compared with wild-type cells
|
hematopoietic system
• exacerbated in mice infected with murine AIDS virus (LP-BM5 strain of Mo-MLV)
|
growth/size/body
• exacerbated in mice infected with murine AIDS virus (LP-BM5 strain of Mo-MLV)
|